Post-ERCP Bleeding: Risk Factors, Prevention, and First Response
Journal of Digestive Endoscopy · 01.03.2026 · 17 (S 01 S 01) · S1-S138
DOI: 10.1055/s-0046-1828833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Digestive Endoscopy, erschienen am 01.03.2026. Verfasst von Mandhir Kumar und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Endoscopic retrograde cholangiopancreatography (ERCP) remains one of the most technically demanding therapeutic procedures in gastrointestinal endoscopy. Despite remarkable advances in endoscopic accessories, imaging, and operator expertise, procedure-related adverse events continue to occur in 5–12% of patients. According to latest meta-analysis, the pooled overall incidence of major ERCP-related adverse events was 4.6%. Post-ERCP pancreatitis (6.5% in first-time ERCP) 1.5%, clinically significant bleeding (1.9% in first-time ERCP) 2.5%, cholangitis (1.9% in first-time ERCP) 0.8%, cholecystitis (1.1% in first-time ERCP), 0.5% perforation (0.6% in first-time ERCP), and 0.2% for ERCP-attributable mortality (0.3% in first-time ERCP). Although the overall incidence of clinically significant bleeding is relatively low (1.5%), bleeding can result in prolonged hospitalization, blood transfusion, repeat endoscopic intervention, angiographic embolization, surgery, and occasionally mortality. Most bleeding episodes are directly related to endoscopic sphincterotomy (EST), although bleeding may also arise from ampullary tumors, biopsy sites, pseudoaneurysms, hemobilia, or retroperitoneal vascular injury. With increasing numbers of elderly patients, widespread use of antithrombotic agents, and expanding indications for ERCP, prevention and prompt management of post-ERCP bleeding have become increasingly relevant in daily clinical practice.
Objective
To provide a comprehensive and evidence-based review of post-ERCP bleeding, emphasizing patient-related and procedure-related risk factors, preventive strategies before and during ERCP, early recognition, and a structured stepwise approach to initial management and rescue therapy.
Discussion
Post-ERCP bleeding is broadly classified as immediate or delayed. Immediate bleeding occurs during ERCP and is usually recognized endoscopically, whereas delayed bleeding may develop several hours to weeks after the procedure and typically presents with melena, hematemesis, anemia, or hemodynamic instability. Multiple risk factors contribute to bleeding. Patient-related factors include coagulopathy, thrombocytopenia, cholangitis, cirrhosis, chronic kidney disease, dialysis dependence, and ongoing anticoagulant or antiplatelet therapy. Procedure-related factors such as endoscopic sphincterotomy, needle-knife precut sphincterotomy, large sphincterotomy, difficult cannulation, balloon dilation following sphincterotomy, ampullary neoplasms, altered surgical anatomy, and intraprocedural bleeding substantially increase risk. Technical factors including inappropriate sphincterotomy direction, excessive incision length, and improper electrosurgical settings further contribute to hemorrhagic complications. Prevention begins before the endoscope is introduced. Careful assessment of bleeding risk, correction of coagulopathy, optimization of platelet counts, treatment of cholangitis, and evidence-based peri-procedural management of antithrombotic medications significantly reduce adverse outcomes. During ERCP, meticulous sphincterotomy technique, controlled incremental incision, appropriate electrosurgical current selection, and avoidance of unnecessary extension of the papillotomy are essential preventive measures. In selected high-risk patients, endoscopic limited sphincterotomy followed by large balloon dilation may reduce bleeding risk while maintaining therapeutic efficacy. Successful management depends upon rapid recognition and prompt intervention. Initial management prioritizes airway protection, hemodynamic stabilization, intravenous fluid resuscitation, blood transfusion when indicated, correction of coagulation abnormalities, and timely repeat endoscopy. Endoscopic therapy remains the cornerstone of treatment. Most often post sphincterotomy bleeding occurs at apex and is a risk factor for delayed bleeding. This can stop spontaneously but may require some maneuvers or diluted epinephrine injection. Other options include thermal coagulation, argon plasma coagulation, coagulation forceps, and endoscopic clipping where technically feasible. Through-the-scope clips deployment is effective but challenging through a duodenoscope. Regardless of the technique used, every effort should be made to avoid trauma to the pancreatic orifice. When standard hemostatic technique failed then fully covered self-expandable metal stents (FCSEMS) has emerged as an effective rescue modality for refractory bleeding by providing immediate tamponade of the papillotomy site, achieving hemostatic success rates exceeding 90% in published series. Patients with persistent or recurrent hemorrhage despite endoscopic therapy should undergo early angiographic embolization, while surgery is reserved for rare cases in whom minimally invasive approaches fail. Special clinical situations including cirrhosis, end-stage renal disease, anticoagulant therapy, and ampullary malignancies require individualized strategies because of their heightened bleeding risk. A multidisciplinary approach involving gastroenterologists, interventional radiologists, anesthesiologists, surgeons, and hematologists is often necessary for optimal outcomes.
Conclusion
Post-ERCP bleeding remains a potentially life-threatening but largely preventable complication. Appropriate patient selection, meticulous procedural technique, and adherence to evidence-based periprocedural protocols significantly reduce bleeding risk. Early recognition, systematic resuscitation, and timely endoscopic intervention remain the foundation of successful management, while FCSEMS and angiographic embolization have transformed the treatment for refractory hemorrhage. A standardized algorithm integrating risk stratification, prevention, early diagnosis, and escalation of therapy can improve clinical outcomes and minimize procedure-related morbidity in contemporary ERCP practice. Publication History Article published online: 27 August 2026 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Private Limited A-13A, Graphix Tower 1, 6th floor, Sector 62, Noida 201309, Uttar Pradesh, India
Zitieren
APA
Kumar, M., & Garg, A. (2026). Post-ERCP Bleeding: Risk Factors, Prevention, and First Response. Journal of Digestive Endoscopy, 17(S 01 S 01), S1-S138. https://doi.org/10.1055/s-0046-1828833
Vancouver
Kumar M, Garg A. Post-ERCP Bleeding: Risk Factors, Prevention, and First Response. Journal of Digestive Endoscopy. 2026;17(S 01 S 01):S1-S138. doi:10.1055/s-0046-1828833
BibTeX
@article{Kumar2026,
author = {Kumar, Mandhir and Garg, Aman},
title = {Post-ERCP Bleeding: Risk Factors, Prevention, and First Response},
journal = {Journal of Digestive Endoscopy},
year = {2026},
volume = {17},
number = {S 01 S 01},
pages = {S1--S138},
doi = {10.1055/s-0046-1828833}
}
EUVIMED